Læknablaðið - 15.03.2013, Blaðsíða 31

Y F I R L I T
40. Oddsson SJ, Hardarson S, Petursdottir V, Jonsson E,
Sigurdsson MI, Einarsson GV, et al. Synchronous pulmon-
ary metastases from renal cell carcinoma-a whole nation
study on prevalence and potential resectability. Scand J
Surg 2012; 101:160-5.
41. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen
A, Magnusson J, Einarsson GV. Histological subtyping
and nuclear grading of renal cell carcinoma and their
implications for survival: a retrospective nation-wide
study of 629 patients. Eur Urol 2005; 48: 593-600.
42. Ravaud A, Audhuy B, Gomez F, Escudier B, Lesimple T,
Chevreau C, et al. Subcutaneous interleukin-2, interferon
alfa-2a, and continuous infusion of fluorouracil in
metastatic renal cell carcinoma: a multicenter phase II trial.
Groupe Francais d>Immunotherapie. J Clin Oncol 1998; 16:
2728-32.
43. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD,
Bukowski RM, Oudard S, et al. Overall survival and
updated results for sunitinib compared with interferon
alfa in patients with metastatic renal cell carcinoma. J Clin
Oncol 2009; 27:3584-90.
44. Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T,
Maeda J, Okami J, et al. Long-term results of surgical
resection for pulmonary metastasis from renal cell
carcinoma: a 25-year single-institution experience. Eur J
Cardiothorac Surg 2011; 39:167-72.
45. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg
FW, Fuerst H. Long-term results after pulmonary resection
of renal cell carcinoma metastases. Ann Thorac Surg 2002;
73:1082-7.
46. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich
BC, Blute ML. Survival after complete surgical resection
of multiple metastases from renal cell carcinoma. Cancer
2011; 117:2873-82.
47. Goorin AM, Shuster JJ, Baker A, Horowitz ME, Meyer
WH, Link MP. Changing pattem of pulmonary metastases
with adjuvant chemotherapy in patients with osteosar-
coma: results from the multiinstitutional osteosarcoma
study. J Clin Oncol 1991; 9: 600-5.
48. Suzuki M, Iwata T, Ando S, Iida T, Nakajima T, Ishii T,
et al. Predictors of long-term survival with pulmonary
metastasectomy for osteosarcomas and soft tissue sarco-
mas. J Cardiovasc Surg (Torino) 2006; 47: 603-8.
49. Briccoli A, Rocca M, Salone M, Bacci G, Ferrari S, Balladelli
A, et al. Resection of recurrent pulmonary metastases in
patients with osteosarcoma. Cancer 2005; 104:1721-5.
50. Antunes M, Bemardo J, Salete M, Prieto D, Eugenio L,
Tavares P. Excision of pulmonary metastases of osteogenic
sarcoma of the limbs. Eur J Cardiothorac Surg 1999; 15:
592-6.
51. Cormier J. Soft tissue sarcomas. Ritstj Brunicardi CF.
McGraw-Hill 2010.
52. Pfannschmidt J, Hoffmann H, Schneider T, Dienemann H.
Pulmonary metastasectomy for soft tissue sarcomas: is it
justified? Recent Results Cancer Res 2009; 179: 321-36.
53. Lee ML, Tomsu K, Von Eschen KB. Duration of survival
for disseminated malignant melanoma: results of a meta-
analysis. Melanoma Res 2000; 10:81-92.
54. Schuhan C, Muley T, Dienemann H, Pfannschmidt J.
Sur\'ival after pulmonary metastasectomy in patients with
malignant melanoma. Thorac Cardiovasc Surg 2011; 59:
158-62.
55. Tafra L, Dale PS, Wanek LA, Ramming KP, Morton DL.
Resection and adjuvant immunotherapy for melanoma
metastatic to the lung and thorax. J Thorac Cardiovasc
Surg 1995; 110:119-28; discussion 129.
56. McDonald ML, Deschamps C, Ilstrup DM, Allen MS,
Trastek VF, Pairolero PC. Pulmonary resection for metasta-
tic breast cancer. Ann Thorac Surg 1994; 58:1599-602.
57. Tanaka F, Li M, Hanaoka N, Bando T, Fukuse T, Hasegawa
S, Wada. Surgery for pulmonary nodules in breast cancer
patients. Ann Thorac Surg 2005; 79: 1711-4; discussion
1714-5.
58. Welter S, Jacobs J, Krbek T, Totsch M, Stamatis G.
Pulmonary metastases of breast cancer. When is resection
indicated? Eur J Cardiothorac Surg 2008; 34:1228-34.
59. Friedel G, Pastorino U, Ginsberg RJ, Goldstraw P,
Johnston M, Pass H, et al. Results of lung metastasectomy
from breast cancer: prognostic criteria on the basis of 467
cases of the Intemational Registry of Lung Metastases. Eur
J Cardiothorac Surg 2002; 22: 335-44.
60. Orrason AW, Agnarsson BA, Geirsson G, Helgason HH,
Gudbjartsson T. Krabbamein í eistum á íslandi 2000-2009:
Nýgengi og lífshorfur. Læknablaðið 2011; 97:143-8.
61. Pfannschmidt J, Hoffmann H, Dienemann H. Thoracic
metastasectomy for nonseminomatous germ cell tumors.
J Thorac Oncol 2010; 5: S182-186.
62. Kesler KA, Wilson JL, Cosgrove JA, Brooks JA, Messiha A,
Fineberg NS, et al. Surgical salvage therapy for malignant
intrathoracic metastases from nonseminomatous germ cell
cancer of testicular origin: analysis of a single-institution
experience. J Thorac Cardiovasc Surg 2005; 130:408-15.
ENGLISH SUMMARY
Pulmonary metastasectomy - a review on indications and outcome
Vidarsdottir H', Moller PH24, Gudbjartsson T3'4
In lceland every third individual is diagnosed with malignant disease;
cancer being the cause of death in one out of four individuals with only
cardiovascular diseases being more common cause of death. Approx-
imately one third of cancer patients are diagnosed with lung metastases
making the lungs one of the most common metastatic site. In some of
these patients a metastasectomy is a treatment option with the intention
of improving survival. In this evidence-based review, the indications and
outcome of pulmonary metastasectomy are discussed. This review is
aimed at doctors within different specialties where lcelandic studies on
pulmonary metastasectomy are referred to.
Key words: Pulmonary metastasectomy, lung metastases, indications, surgical technique, prognostic factors, survival.
Correspondence: Halla Viöarsdóttir, halla.vidarsdottir@skane.se
'Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden, ‘Department of Surgery, Landspltali Universlty Hospltal, 3Department of Cardiothoracic Surgery, Landspitali
University Hospital, ‘Faculty of Medicine, University of lceland, Reykjavik.
LÆKNAblaðið 2013/99 143